View More Recent Stories
-
PreveCeutical's Subsidary, Biogene Therapeutics Announces Strategic Appointments: Dr. Linnea Olofsson as Chief Scientific Officer and Dr. Harry Parekh as Chief Research Officer
-
PreveCeutical Announces Closing of BioGene Therapeutics Transaction
-
PreveCeutical's Subsidiary, BioGene Therapeutics, Appoints President
-
PreveCeutical Launches Strategic Partnership with BioGene Therapeutics
-
PreveCeutical Engages Phoenix Corporate Finance Inc. to Provide Advisory Services
-
PreveCeutical Engages Outside The Box Capital Inc. to Provide Marketing Services
-
Preveceutical Announces Revocation of Management Cease Trade Order
-
PreveCeutical Provides Update on Management Cease Trade Order
-
PreveCeutical Enters into Loan Agreements
-
PreveCeutical Provides Update on Management Cease Trade Order

